Literature DB >> 4708639

The use of propranolol in the surgical treatment of thyrotoxic patients.

T C Lee, R J Coffey, J Mackin, M Cobb, J Routon, J J Canary.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4708639      PMCID: PMC1355934     

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.

Authors:  J W BLACK; A F CROWTHER; R G SHANKS; L H SMITH; A C DORNHORST
Journal:  Lancet       Date:  1964-05-16       Impact factor: 79.321

2.  Radiothyroxine turnover studies in myxedema, thyrotoxicosis, and hypermetabolism without endocrine disease.

Authors:  K STERLING; R B CHODOS
Journal:  J Clin Invest       Date:  1956-07       Impact factor: 14.808

3.  Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state.

Authors:  P Turner; K L Granville-Grossman
Journal:  Lancet       Date:  1965-12-25       Impact factor: 79.321

4.  The use and abuse of beta-adrenergic blockade in the surgery of hyperthyroidism.

Authors:  B Pimstone; B Joffe
Journal:  S Afr Med J       Date:  1970-09-19

5.  Sympathetic nervous system blocking in hyperthyroidism.

Authors:  A I Vinik; B L Pimstone; R Hoffenberg
Journal:  J Clin Endocrinol Metab       Date:  1968-05       Impact factor: 5.958

6.  Beta-adrenergic blockade in thyrotoxic myopathy.

Authors:  N Pimstone; N Marine; B Pimstone
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

7.  Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias.

Authors:  V Parsons; D Jewitt
Journal:  Postgrad Med J       Date:  1967-12       Impact factor: 2.401

  7 in total
  17 in total

1.  Current status of Beta blocker therapy.

Authors:  J D Gray
Journal:  Can Fam Physician       Date:  1980-05       Impact factor: 3.275

2.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

3.  Preoperative treatment of thyrotoxicosis in developing countries: a comparative study of carbimazole and propranolol.

Authors:  J F Haddad; S Tibblin
Journal:  Ann R Coll Surg Engl       Date:  1988-11       Impact factor: 1.891

4.  The clinical importance of the sympathetic nervous system in Graves' disease.

Authors:  D G McDevitt
Journal:  Ir J Med Sci       Date:  1977-11       Impact factor: 1.568

Review 5.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

6.  Thyroid surgery for Graves' disease.

Authors:  A D Toft
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-05

Review 7.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

8.  Propranolol in the surgical management of thyrotoxicosis.

Authors:  P D Bewsher; C A Pegg; D J Stewart; D A Lister; W Michie
Journal:  Ann Surg       Date:  1974-11       Impact factor: 12.969

9.  Propranolol and thyroidectomy in the treatment of thyrotoxicosis.

Authors:  T C Lee; R J Coffey; B M Currier; X P Ma; J J Canary
Journal:  Ann Surg       Date:  1982-06       Impact factor: 12.969

10.  The selective beta 1-blocking agent metoprolol compared with antithyroid drug and thyroxine as preoperative treatment of patients with hyperthyroidism. Results from a prospective, randomized study.

Authors:  A Adlerberth; G Stenström; P O Hasselgren
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.